International Board of Directors Election

ISPE International Board of Directors Election Process

The ISPE International Board of Directors 2021 Election is open 2 June through 27 July 2021. Ballots will be emailed to all ISPE Members eligible to vote. The email contains a personal URL to access the ballot, review the nomination materials, and to cast your vote online. The personal URL can be used only once, and it can be used only by the Member to whom it was assigned.

Please review all candidate information and ballot instructions carefully prior to submitting your ballot. Once you have submitted your vote, you will not be able to recast your ballot.

Voting Instructions

If you encounter an error during the voting process, please contact Keith Wier, Account Manager, Intelliscan, Inc. by telphone or email. Candidates have been selected by the Nominating Committee and then approved by the ISPE Board of Directors as required in ISPE’s bylaws. We now present the nominees to you for your consideration.

  • Your ballot instructions will indicate that you can vote for one person for each Officer position and four people for the Director positions. This could be either votes for candidates listed, write in votes for any other ISPE Member, or a combination.
  • To ensure that our Board reflects the ISPE membership demographics, the Nominating Committee designed a paired slate. On your ballot, you will vote for two (2) Director candidates per group for a total of four (4) votes.

Directors are elected to a two-year term and can serve up to two terms consecutively. The officer positions on the ballot are Chair, Vice Chair, Treasurer, and Secretary. The current Chair automatically becomes Past Chair in the next year and the President serves as a non-voting ex-officio member. Terms for officers are one year and the Secretary is the first officer position in the typical officer succession. Each candidate for secretary is typically making a five-year commitment to serve in the roles of Secretary through Past Chair.

All voting must be completed no later than 11:59 PM Eastern Daylight Time, Tuesday, 27 July 2021.

View the current ISPE International Board of Directors.


Meet the 2021 Candidates

Officer Candidates

Jörg Zimmermann
Vice President, Vetter Development Service, External Affairs
Vetter Pharma-Fertigung GmbH & Co.
Chair
Michael L. Rutherford
Executive Director, Computer Systems Quality & Data Integrity
Syneos Health
Vice Chair
Scott W. Billman
Global Head of Engineering
Biogen
Treasurer
Jeffrey A. Biskup, PE
CEO and Chairman of the Board
CRB
Secretary

Director Candidates

Ylva Ek
Chief Quality Officer (CQO)
KeyPlants AB
Seeking Second Term
Eamon P. Judge
EMEA Global Projects Planning Leader
Eli Lilly SA Irish Branch
Lou W. Kennedy
CEO and Owner
Nephron Pharmaceuticals
Seeking Second Term
Georg Singewald, PhD
VP, Head of Global Quality Control
Genentech, A Member of the Roche Group
Timothy J.N. Watson, PhD
Executive Director & Team Leader, CMC Advisory Office
Pfizer Inc
Andrew F. Wirths
Sr Vice President Americas Supply
AstraZeneca

Board Members Continuing a Term in 2021-2022

The following individuals will be continuing a two-year term in 2021-2022.

Joanne R. Barrick, RPh
Advisor, Global Validation
Eli Lilly and Company
Chair
Automatically becomes Past Chair 2021-2022
Vivianne J. Arencibia
Independent Consultant
Arencibia Quality Compliance Associates
Nina S. Cauchon, PhD
Director Regulatory Affairs - CMC
Amgen Inc.
Chris Chen, PhD
CEO
WuXi Biologics (Shanghai) Co., Ltd.
David Doleski
Compliance Head for Biologics Quality Operations
Sanofi
Teresa Minero
Founder & CEO
LifeBee - Digitalizing Life Sciences
Hirofumi Suzuki, PhD
Senior Regulatory CMC Adviser
Bayer Yakuhin Ltd

Board Members Completing Their Service

The following individuals will complete their Board service and will officially end their term at the 2021 ISPE Annual Meeting. ISPE thanks these individuals for their dedication and commitment to the organization.

Frances M. Zipp
President & CEO
Lachman Consultant Services
Past Chair
Stephen C. Mahoney, JD
Executive Director, Global Quality & Compliance
Genentech, A Member of the Roche Group
Alice Redmond, PhD
Chief Strategy Officer
CAI

Candidate Nomination and Selection Process

Below are the steps taken for selecting candidates to be on the ballot:

  • Each year, the global membership of ISPE are asked to provide the names of potential candidates to the ISPE Nominating Committee. Candidates are proposed on the basis of a number of considerations communicated in the call for nominations including: strategic thinking, leadership skills, “business sense,” knowledge of the global pharma / biopharma industry, and the ability to commit the time and resources required to actively participate on the Board.
  • The Nominating Committee proposes a list of potential candidates for the vacancies on the Executive Committee and the International Board of Directors. The Board approves this list before the election.
  • Approved candidates are asked to confirm their willingness to stand for the election and to demonstrate that they have the support of their employer to serve.
  • Following the receipt of this information, the balloting process is arranged using an independent outside body, Intelliscan, Inc.

Intelliscan, Inc. conducts the entire election process and reports the results to the International Board of Directors.